Gene therapy may be a ground-breaking technology, but FDA appears to be embracing many of its existing practices in new guidances intended to encourage the products' development in rare diseases.
The Center for Biologics Evaluation and Research on July 11 issued six long-anticipated draft guidances on gene therapy development. Three...







